Skip to main content
Clinical Trials/NCT05133817
NCT05133817
Completed
Not Applicable

Prophylactic Norepinephrine Infusion Combined With 6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension in Patients Undergoing Cesarean Section: A Randomized, Controlled, Dose-finding Trial

General Hospital of Ningxia Medical University1 site in 1 country175 target enrollmentNovember 26, 2021

Overview

Phase
Not Applicable
Intervention
Normal saline
Conditions
Adverse Event
Sponsor
General Hospital of Ningxia Medical University
Enrollment
175
Locations
1
Primary Endpoint
The incidence of post-spinal anesthesia hypotension
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to investigate the suitable infusion dose of prophylactic norepinephrine infusion combined with 6% Hydroxyethyl starch (130/0.4) coload for post-spinal anesthesia hypotension in patients undergoing cesarean section.

Detailed Description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Vasopressor has been highly recommended for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential substitute drug for phenylephrine, norepinephrine has gradually been used in parturients undergoing cesarean section. There's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. But the ideal infusion dose of norepinephrine with colloid coload is still unknown. The purpose of this study is to investigate the suitable infusion dose of prophylactic norepinephrine infusion combined with 6% Hydroxyethyl starch (130/0.4) coload for post-spinal anesthesia hypotension in patients undergoing cesarean section.

Registry
clinicaltrials.gov
Start Date
November 26, 2021
End Date
September 3, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
General Hospital of Ningxia Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-40 years
  • Primipara or multipara
  • Singleton pregnancy ≥ 37 weeks
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for elective cesarean section under spinal anesthesia

Exclusion Criteria

  • Body height \< 150 cm
  • Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
  • Hemoglobin \< 7g/dl
  • Coagulation or renal function disorders
  • Known allergy to hydroxyethyl starch
  • Fetal distress, or known fetal developmental anomaly

Arms & Interventions

Control group

Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of normal saline by IV infusion.

Intervention: Normal saline

0.025 μg/kg/min group

Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of norepinephrine (0.025 μg/kg/min) by IV infusion.

Intervention: Norepinephrine (0.025 μg/kg/min)

0.05 μg/kg/min group

Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of norepinephrine (0.05 μg/kg/min) by IV infusion.

Intervention: Norepinephrine (0.05 μg/kg/min)

0.075 μg/kg/min group

Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of norepinephrine (0.075 μg/kg/min) by IV infusion.

Intervention: Norepinephrine (0.075 μg/kg/min)

0.1μg/kg/min group

Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of norepinephrine (0.1μg/kg/min) by IV infusion.

Intervention: Norepinephrine (0.1 μg/kg/min)

Outcomes

Primary Outcomes

The incidence of post-spinal anesthesia hypotension

Time Frame: 1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 80% of the baseline

Secondary Outcomes

  • The incidence of severe post-spinal anesthesia hypotension.(1-15 minutes after spinal anesthesia)
  • The incidence of hypertension.(1-15 minutes after spinal anesthesia)
  • Concentration of base excess(Immediately after fetal delivery)
  • Apgar score (0-10; a higher score means a better outcome)(5 min after fetal delivery)
  • The incidence of bradycardia.(1-15 minutes after spinal anesthesia)
  • Partial pressure of oxygen(Immediately after fetal delivery)
  • Overall stability of systolic blood pressure control versus baseline(1-15 minutes after spinal anesthesia)
  • The incidence of nausea and vomiting.(1-15 minutes after spinal anesthesia)
  • pH value(Immediately after fetal delivery)
  • Apgar score (0-10;a higher score means a better outcome)(5 min after fetal delivery)

Study Sites (1)

Loading locations...

Similar Trials